Cargando…
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293382/ https://www.ncbi.nlm.nih.gov/pubmed/37193879 http://dx.doi.org/10.1007/s40257-023-00784-6 |
| _version_ | 1785062989463814144 |
|---|---|
| author | Silverberg, Jonathan I. Lynde, Charles W. Abuabara, Katrina Patruno, Cataldo de Benedetto, Anna Zhang, Haixin Thomas, Ryan B. Bégo-Le-Bagousse, Gaëlle Khokhar, Faisal A. Vakil, Jignesh Marco, Ainara Rodríguez Levit, Noah A. |
| author_facet | Silverberg, Jonathan I. Lynde, Charles W. Abuabara, Katrina Patruno, Cataldo de Benedetto, Anna Zhang, Haixin Thomas, Ryan B. Bégo-Le-Bagousse, Gaëlle Khokhar, Faisal A. Vakil, Jignesh Marco, Ainara Rodríguez Levit, Noah A. |
| author_sort | Silverberg, Jonathan I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10293382 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102933822023-06-28 Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials Silverberg, Jonathan I. Lynde, Charles W. Abuabara, Katrina Patruno, Cataldo de Benedetto, Anna Zhang, Haixin Thomas, Ryan B. Bégo-Le-Bagousse, Gaëlle Khokhar, Faisal A. Vakil, Jignesh Marco, Ainara Rodríguez Levit, Noah A. Am J Clin Dermatol Publisher Correction Springer International Publishing 2023-05-17 2023 /pmc/articles/PMC10293382/ /pubmed/37193879 http://dx.doi.org/10.1007/s40257-023-00784-6 Text en © Springer Nature Switzerland AG 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Publisher Correction Silverberg, Jonathan I. Lynde, Charles W. Abuabara, Katrina Patruno, Cataldo de Benedetto, Anna Zhang, Haixin Thomas, Ryan B. Bégo-Le-Bagousse, Gaëlle Khokhar, Faisal A. Vakil, Jignesh Marco, Ainara Rodríguez Levit, Noah A. Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials |
| title | Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials |
| title_full | Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials |
| title_fullStr | Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials |
| title_full_unstemmed | Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials |
| title_short | Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials |
| title_sort | publisher correction to: efficacy and safety of dupilumab maintained in adults ≥ 60 years of age with moderate-to-severe atopic dermatitis: analysis of pooled data from four randomized clinical trials |
| topic | Publisher Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293382/ https://www.ncbi.nlm.nih.gov/pubmed/37193879 http://dx.doi.org/10.1007/s40257-023-00784-6 |
| work_keys_str_mv | AT silverbergjonathani publishercorrectiontoefficacyandsafetyofdupilumabmaintainedinadults60yearsofagewithmoderatetosevereatopicdermatitisanalysisofpooleddatafromfourrandomizedclinicaltrials AT lyndecharlesw publishercorrectiontoefficacyandsafetyofdupilumabmaintainedinadults60yearsofagewithmoderatetosevereatopicdermatitisanalysisofpooleddatafromfourrandomizedclinicaltrials AT abuabarakatrina publishercorrectiontoefficacyandsafetyofdupilumabmaintainedinadults60yearsofagewithmoderatetosevereatopicdermatitisanalysisofpooleddatafromfourrandomizedclinicaltrials AT patrunocataldo publishercorrectiontoefficacyandsafetyofdupilumabmaintainedinadults60yearsofagewithmoderatetosevereatopicdermatitisanalysisofpooleddatafromfourrandomizedclinicaltrials AT debenedettoanna publishercorrectiontoefficacyandsafetyofdupilumabmaintainedinadults60yearsofagewithmoderatetosevereatopicdermatitisanalysisofpooleddatafromfourrandomizedclinicaltrials AT zhanghaixin publishercorrectiontoefficacyandsafetyofdupilumabmaintainedinadults60yearsofagewithmoderatetosevereatopicdermatitisanalysisofpooleddatafromfourrandomizedclinicaltrials AT thomasryanb publishercorrectiontoefficacyandsafetyofdupilumabmaintainedinadults60yearsofagewithmoderatetosevereatopicdermatitisanalysisofpooleddatafromfourrandomizedclinicaltrials AT begolebagoussegaelle publishercorrectiontoefficacyandsafetyofdupilumabmaintainedinadults60yearsofagewithmoderatetosevereatopicdermatitisanalysisofpooleddatafromfourrandomizedclinicaltrials AT khokharfaisala publishercorrectiontoefficacyandsafetyofdupilumabmaintainedinadults60yearsofagewithmoderatetosevereatopicdermatitisanalysisofpooleddatafromfourrandomizedclinicaltrials AT vakiljignesh publishercorrectiontoefficacyandsafetyofdupilumabmaintainedinadults60yearsofagewithmoderatetosevereatopicdermatitisanalysisofpooleddatafromfourrandomizedclinicaltrials AT marcoainararodriguez publishercorrectiontoefficacyandsafetyofdupilumabmaintainedinadults60yearsofagewithmoderatetosevereatopicdermatitisanalysisofpooleddatafromfourrandomizedclinicaltrials AT levitnoaha publishercorrectiontoefficacyandsafetyofdupilumabmaintainedinadults60yearsofagewithmoderatetosevereatopicdermatitisanalysisofpooleddatafromfourrandomizedclinicaltrials |